Sensei Biotherapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Sensei Biotherapeutics, Inc. (SNSE) is 14.39

According to Sensei Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.39. This represents a change of 74.99% compared to the average of 8.23 of the last 4 quarters.

Sensei Biotherapeutics, Inc. (SNSE) Historical Current Ratio (quarterly & annually)

How has SNSE Current Ratio performed in the past?

The mean historical Current Ratio of Sensei Biotherapeutics, Inc. over the last ten years is 8.96. The current 14.39 Current Ratio has changed 15.96% with respect to the historical average. Over the past ten years (40 quarters), SNSE's Current Ratio was at its highest in in the March 2021 quarter at 69.81. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Sensei Biotherapeutics, Inc. (SNSE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sensei Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sensei Biotherapeutics, Inc. (SNSE) Average Current Ratio

How has SNSE Current Ratio performed in the past?

The current Current Ratio of Sensei Biotherapeutics, Inc. (SNSE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sensei Biotherapeutics, Inc. (SNSE) Current Ratio vs. Peers

How is SNSE’s Current Ratio compared to its peers?

Sensei Biotherapeutics, Inc.’s Current Ratio is greater than Imunon, Inc. (1.59), greater than Bolt Biotherapeutics, Inc. (3.51), greater than Evogene Ltd. (2.79), greater than Cocrystal Pharma, Inc. (2.66), greater than Dogwood Therapeutics, Inc. (5.86), greater than Marker Therapeutics, Inc. (4.79), greater than Cellectar Biosciences, Inc. (1.90), greater than AEON Biopharma, Inc. (0.99), greater than Cingulate Inc. (2.55), greater than Traws Pharma, Inc. (0.43),

Build a custom stock screener for Sensei Biotherapeutics, Inc. (SNSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sensei Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sensei Biotherapeutics, Inc. (SNSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sensei Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.